- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Rivaroxaban (af) – March 2012
Rivaroxaban (AF), tablet, 15 mg and 20 mg, Xarelto® - March 2012
Last updated
8 November 2023